Novosti
Khirurgii
This journal is
indexed in Scopus

Year 2015 Vol. 23 No 6

REVIEWS

DOI: http://dx.doi.org/10.18484/2305-0047.2015.6.673   |  

А.А. GLUKHOV 1, M.V. ARALOVA2

PATHOPHYSIOLOGY OF PERSISTENT CHRONIC WOUNDS AND CURRENT METHODS OF STIMULATION OF WOUND PROCESS

SBEE HPE "Voronezh State Medical University named after N.N. Burdenko",1
BEH "Voronezh regional clinical hospital N1"2,
The Russian Federation

Treatment of persistent chronic wounds completely differented in the etiology, pathogenesis, clinical pictures so far represents one of the most difficult issues of surgery. At the cellular and subcellular levels they are characterized by existence of a chronic inflammation and signs of all 3 phases of wound process simultaneously. In the article the difficult intercellular and cellular matrix interactions, mediators and regulators the reparative processes, participation of separate cellular elements during various temporary periods in normal and pathological healing, the factors modeling wound process are described. The current data of morphology of tissue regeneration obtained by electron microscopy, immunohistochemical researches, an autoradiography allowing the physicians of surgical specialties to provide the effective search of radical and rational methods of treatment of this problem are presented. The wide range of the new directions of tissue and genetic engineering, the cellular therapy used in practical medicine: the preparations of collagen, agents on the basis of negatively charged inert polystyrene microspheres, use of platelet-rich plasma and the preparations containing growth factors, including an endothelium of vessels, techniques of cultivation of fibroblasts, keratinocytes, epidermal cells have been described. The new technologies which are passing still laboratory researches, but having great clinical prospects are specified.

Keywords: persistent chronic wounds, pathogenesis, wound process, trophic ulcers, local treatment, new methods, perspectives
p. 673-679 of the original issue
References
  1. Chur NN, Grishin IN, Chur SN. Sovremennyi vzgliad na lechenie troficheskikh iazv nizhnikh konechnostei venoznogo geneza [The modern view on the treatment of trophic ulcers of venous origin]. Novosti Khirurgii. 2008;(16)2:139-48.
  2. Alekseeva NT, Glukhov AA, Ostroushko AP. Rol' kletok fibroblasticheskogo differona v protsesse zazhivleniia ran [The role of cells of fibroblast differon in wound healing]. Vestn Eksperiment i Klin Khirurgii. 2012;(5)3:601 - 608.
  3. Alipov VV, Dobreikin EA, Urusova AI, Beliaev PA. Eksperimental'noe obosnovanie sochetannogo primeneniia nanochastits medi i nizkointensivnogo lazernogo oblucheniia pri khirurgicheskom lechenii infitsirovannykh ozhogovykh ran kozhi [Experimental study of combined application of copper nanoparticles and low-intensity laser irradiation in the surgical treatment of infected burn wounds of skin]. Vestn Eksperiment i Klin Khirurgii. 2013;(6)4:411-17.
  4. Shevchenko IL, Stoiko IuM, Gudymovich VG, Ivanov AK. Kompleksnyi podkhod v lechenii obshirnykh troficheskikh iazv golenei v mnogoprofil'nom statsionare [A comprehensive approach in the treatment of extensive trophic ulcers in a multidisciplinary hospital]. Vestn Eksperiment i Klin Khirurgii. 2014;(7)3:221-27.
  5. Wong IK, Andriessen A, Lee DT, Thompson D, Wong LY, Chao DV, So WK, Abel M. Randomized controlled trial comparing treatment outcome of two compression bandaging systems and standard care without compression in patients with venous leg ulcers. J Vasc Surg. 2012 Jan;26(1):102-10. doi: 10.1111/j.1468-3083.2011.04327.x.
  6. Khrupkin VI, Zubritskii VF, Ivashkin AN, Artem'ev AA, Fominykh EM. Dermatoplastika ranevykh defektov [Dermatoplasty of wound defects]. Moscow, RF: GEOTAR-Media. 2009:192.
  7. Kuzin MI, Kostiuchenok BM. Rany i ranevaia infektsiia [Wounds and wound infection]. Rukovodstvo dlia vrachei. Moscow, RF: Meditsina; 1990:592.
  8. Bogdanets LI, Berezina SS, Lobanov VN, Kirienko AI. Stimuliatsiia II-III stadii regeneratsii venoznykh troficheskikh iazv gidroaktivnymi ranevymi pokrytiiami [Stimulation of stage II-III regeneration trophic venous ulcers by hydroactive wound covering]. Khirurgiia. Zhurn im NI Pirogova. 2009;(6):61-66.
  9. Danilov RK. Ranevoi protsess: gistogeneticheskie osnovy [Wound process: the histogenetic foundations]. Saint-Petersburg, RF: VMedA im SM Kirova. 2007: 380.
  10. Wu SC, Marston W, Armstrong DG. Wound care: the role of advanced wound healing technologies. J Vasc Surg. 2010 Sep;52(3 Suppl):59S-66S. doi: 10.1016/j.jvs.2010.06.009.
  11. Kukol'nikova EL, Zhukov BN. Sposob mestnogo lecheniia troficheskikh iazv venoznoi etiologii [The method of local treatment of trophic ulcers of venous etiology]. Khirurgiia. Zhurn im NI Pirogova. 2011;(7):67-69.
  12. Lipnitskii EM. Lechenie troficheskikh iazv nizhnikh konechnostei [Treatment of venous ulcers of the lower extremities]. Moscow, RF: Meditsina; 2001:160.
  13. Alipov V.V. Lazer nanotechnology in experimental surgery. International Kongress EuroMedica. Hannover. 2012;(22):22-23.
  14. Gloviczki P, Yao James S. T. Handbook of venous disorders. London. Arnold; 2001:73-79.
  15. Diegelmann RF, Evans MC. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci. 2004 Jan 1;9:283-89.
  16. Widgerow AD. Chronic wound fluid-thinking outside the box. Wound Repair Regen. 2011 May-Jun;19(3):287-91. doi: 10.1111/j.1524-475X.2011.00683.x.
  17. Koreiba KA, Minabutdinov AR. Bioplasticheskie materialy na osnove nativnogo kollagena I tipa pri lechenii bol'nykh s sindromom diabeticheskoi stopy [Bioplastic materials based on native collagen type I in the treatment of patients with diabetic foot]. Khirurgiia. Zhurn im NI Pirogova. 2014;(10):83-86.
  18. Obolenskii VN, Ermolova DA. Primenenie trombotsitarnykh faktorov rosta i kollagenovykh biopreparatov v lechenii bol'nykh s khronicheskimi troficheskimi iazvami razlichnoi etiologii [The use of platelet growth factors and collagen preparations in the treatment of patients with chronic trophic ulcers of different etiology]. Khirurgiia. 2012;(5):42-47.
  19. Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost. 2004 Jan;91(1):4-15.
  20. Coban YK, Kalender AM. Treatment of gun-shot defect of the foot with bovine collagen matrix application. Foot (Edinb). 2009;19(4):222-23.
  21. Govrin J, Kogan L, Luger E, Tamir J, Zeilig G, Shafir R. New method for treating hard-to-heal wounds: clinical experience. Wounds UK. 2010; 6(4):52-61.
  22. Othman D. Negative pressure wound therapy literature review of efficacy, cost effectiveness, and impact on patients' quality of life in chronic wound management and its implementation in the United Kingdom. Plast Surg Int. 2012:374-98.doi: 10.1155/2012/374398.
  23. Dragunov AG, Aleksandrov IuV, Khripunov SA. Primenenie vnutritkanevogo vvedeniia autoplazmy, obogashchennoi trombotsitami (AOT), pri lechenii ishemii nizhnikh konechnostei [The use of interstitial administration autoplasma platelet rich (APR) in the treatment of lower limb ischemia]. Angiologiia i Sosud Khirurgiia. 2008;(4):17-19.
  24. Committee on Research, Science, and Therapy of the American Academy of Periodontology. The potential role of growth and differentiation factors in periodontal regeneration. J Periodontol. 1996 May;67(5):545-53.
  25. Delgado JJ, Sánchez E, Baro M, Reyes R, Evora C, Delgado A. A platelet derived growth factor delivery system for bone regeneration. J Mater Sci Mater Med. 2012 Aug;23(8):1903-12. doi: 10.1007/s10856-012-4661-z.
  26. Lacci KM, Dardik A. Platelet-rich plasma: support for its use in wound healing. Yale J Biol Med. 2010 Mar; 83(1):1-9.
  27. Galstian GR, Ignat'eva VI, Avksent'eva MV, Dedov II. Kliniko-ekonomicheskii analiz primeneniia preparata epidermal'nogo faktora rosta (Eberprot-P) u bol'nykh s sindromom diabeticheskoi stopy [Clinical and economic analysis of the drug epidermal growth factor (Eberprot-P) in patients with diabetic foot syndrome]. Endokrin Khirurgiia. 2013;(1):4-15.
  28. Sarrazy V, Billet F, Micallef L, Coulomb B, Desmoulière A. Mechanisms of pathological scarring: role of myofibroblasts and current developments. Wound Repair Regen. 2011 Sep;19 Suppl 1:s10-5. doi: 10.1111/j.1524-475X.2011.00708.x.
  29. Scherer S, Tobalem M, Vigato E, Heit Y, Modarressi A, Hinz B, Pittet B, Pietramaggiori G. Nonactivated versus thrombin-activated platelets on wound healing and fibroblast-to-myofibroblast differentiation in vivo and in vitro. Plast Reconstr Surg. 2012 Jan;129(1):46e-54e. doi: 10.1097/PRS.0b013e3182362010.
  30. Deev RV, Grigorian AS, Potapov IV, Kiselev SL, Isaev AA. Mirovoi opyt genoterapii ishemicheskikh zabolevanii [World experience of gene therapy of ischemic diseases]. Angiologiia i Sosud Khirurgiia. 2011;(17)2:145-54.
  31. Gavrilenko AV, Voronov DA. Gennye tekhnologii stimuliatsii angiogeneza kak innovatsionnoe napravlenie v angiologii i sosudistoi khirurgii [Gene technology stimulation of angiogenesis as an innovative direction in the angiology and vascular surgery]. Angiologiia i Sosud Khirurgiia. 2015;(21)2:7-14.
  32. Ferraro B, Cruz Y L, Baldwin M, Coppola D, Heller R. Increased perfusion and angiogenesis in a hindlimb ischemia model with plasmid FGF-2 delivered by noninvasive electroporation. Gene Therapy. 2010;(17):763-69. DOI: 10.1038/gt.2010.43.
  33. Ruiter MS, van Golde JM, Schaper NC, Stehouwer CD, Huijberts MS. Diabetes impairs arteriogenesis in the peripheral circulation: review of molecular mechanisms. Clin Sci (Lond). 2010 Jun 8;119(6):225-38. doi: 10.1042/CS20100082.
  34. Milanov NO, Startseva OI, Istranov AT, Mel'nikov DV, Zakharenko AS. Perspektivy klinicheskogo primeneniia stvolovykh kletok zhirovoi tkani v plasticheskoi khirurgii i regenerativnoi meditsine [Prospects for the clinical application of stem cells in the adipose tissue of plastic surgery and regenerative medicine]. Khirurgiia. Zhurn im NI Pirogova. 2014;(5):71-74.
  35. Porter S. The role of the fibroblast in wound contraction and healing. Wounds UK. 2007;(3):33-40.
  36. Babushkina IV. Vliianie nanochastits metallov na regeneratsiiu eksperimental'nykh ran [Influence of metal nanoparticles on the regeneration of experimental wounds]. Vestn Eksperiment i Klin Khirurgii. 2013;(6)2:217- 21.
  37. Jørgensen B, Karlsmark T, Vogensen H, Haase L, Lundquist R. A pilot study to evaluate the safety and clinical performance of Leucopatch, an autologous, additive-free, platelet-rich fibrin for the treatment of recalcitrant chronic wounds. Int J Low Extrem Wounds. 2011 Dec;10(4):218-23. doi: 10.1177/1534734611426755.
  38. Glukhov AA, Zuikova AA, Petrova TN, Andreev AA, Ostroushko AP. Kliniko-patogeneticheskoe obosnovanie primeneniia antimikoticheskikh sredstv v kompleksnom lechenii patsientov s sindromom diabeticheskoi stopy [Clinico-pathogenetic substantiation of application of antifungal agents in treatment of patients with diabetic foot syndrome]. Vestn Eksperiment i Klin Khirurgii. 2012;(5)4:639-43.
Address for correspondence:
396310, Rossiiskaia Federatsiia, g. Voronezh, Moskovskii prospekt, d. 151, "Voronezhskaia oblastnaia klinicheskaia bol'nitsa №1" otdelenie ambulatorno-poliklinicheskoi khirurgii, tel. rab.: 8 803 854 05 43,
e-mail: Mashaaralova@mail.ru,
Aralova Mariia Valer'evna
Information about the authors:
Glukhov A.A., MD, professor, a head of the department of general surgery Medical University "Voronezh State Medical University named after N.N. Burdenko".
Aralova M.V. PhD, a head of the department of outpatient surgery BEH "Voronezh regional clinical hospital N1".
Contacts | ©Vitebsk State Medical University, 2007